India's drug regulatory authority, the Central Drugs Standard Control Organisation (CDSCO), has issued a clear advisory stating that injectable cosmetic products are not permitted under the existing legal framework. This announcement comes in response to the increasing trend of aesthetic clinics and wellness centres promoting injectable treatments as cosmetic procedures across the country.
Regulatory Warning on Injectable Aesthetic Treatments
The CDSCO emphasized that no injectable product intended for cosmetic purposes has been approved for use in India. The advisory specifically targets beauty clinics and wellness centres that offer services such as dermal fillers, botulinum toxin injections, and other injectable aesthetic treatments marketed as cosmetic enhancements. According to the regulator, these products fall outside the scope of legally permitted cosmetics under the Drugs and Cosmetics Act.
Concerns Over Safety and Unapproved Use
The advisory highlights significant safety concerns associated with unapproved injectable products. The CDSCO noted that the use of such substances without proper regulatory oversight poses serious health risks, including allergic reactions, infections, and long-term complications. The regulator urged consumers to avoid undergoing any injectable cosmetic procedures at unlicensed facilities and to verify the credentials of practitioners.
This move by the CDSCO aims to protect public health by curbing the unregulated proliferation of injectable treatments. The regulator has also warned that any clinic or individual found administering these products could face legal action, including penalties and prosecution under the Drugs and Cosmetics Act.
Growing Popularity of Aesthetic Procedures
The advisory comes amid a surge in demand for non-surgical cosmetic treatments in India. Injectable procedures, such as anti-wrinkle injections and dermal fillers, have become increasingly popular in urban areas, often promoted through social media and celebrity endorsements. However, many of these treatments are performed without adequate medical supervision or regulatory compliance, raising alarms among health authorities.
Legal Framework and Next Steps
Under current Indian law, cosmetic products are defined as items intended for external application to clean, beautify, or promote attractiveness. Injectable products, being administered through the skin, do not meet this definition and are therefore classified as drugs or medical devices requiring rigorous approval. The CDSCO has reiterated that no injectable cosmetic product has been granted marketing authorization in the country.
The regulator has advised all state drug controllers to enforce the advisory strictly and conduct inspections of beauty clinics and wellness centres to ensure compliance. Consumers are encouraged to report any instances of unauthorized injectable treatments to the nearest drug control office. The CDSCO has also indicated that it will review the regulatory framework to address emerging trends in aesthetic medicine while ensuring patient safety.
